Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Current Medical Research and Opinion
|
July 19, 2006
Effects of a global risk educational tool on primary coronary prevention: the Atherosclerosis Assessment Via Total Risk (AVIATOR) study
Terry A Jacobson, Stephen W Gutkin, Charles R Harper
European Journal of Endocrinology
|
March 7, 2008
Exploiting the antidiabetic properties of incretins to treat type 2 diabetes mellitus: glucagon-like peptide 1 receptor agonists or insulin for patients with inadequate glycemic control?
Luc F Van Gaal, Stephen W Gutkin, Michael A Nauck
Journal of Cardiovascular Pharmacology
|
April 23, 2008
Effects of modifying triglycerides and triglyceride-rich lipoproteins on cardiovascular outcomes
Madiha Abdel-Maksoud, Vasilisa Sazonov, Stephen W Gutkin, et al.
Clinicoeconomics and Outcomes Research : CEOR
|
June 21, 2018
A systematic literature review of the clinical and health economic burden of schizophrenia in privately insured patients in the United States
Wenjie Zhang, Tony B Amos, Stephen W Gutkin, et al.
Child and Adolescent Psychiatry and Mental Health
|
May 17, 2011
Time courses of improvement and symptom remission in children treated with atomoxetine for attention-deficit/hyperactivity disorder: analysis of Canadian open-label studies
Ruth A Dickson, Ellen Maki, Christopher Gibbins, et al.
Journal of the American Academy of Nurse Practitioners
|
June 9, 2011
Optimizing treatment outcomes with phosphodiesterase type 5 inhibitors for erectile dysfunction: opening windows to enhanced sexual function and overall health
Richard Sadovsky, Gerald B Brock, Mikel Gray, et al.
Current Medical Research and Opinion
|
December 7, 2007
Effects of ezetimibe, simvastatin, atorvastatin, and ezetimibe-statin therapies on non-cholesterol sterols in patients with primary hypercholesterolemia
Gerd Assmann, Frank Kannenberg, Dena R Ramey, et al.
Cancer Diagnosis & Prognosis
|
March 4, 2026
<i>BCR::ABL1</i> Mutational Profiling in US Patients With Chronic-phase Chronic Myeloid Leukemia on Tyrosine Kinase Inhibitors
Fadi G Haddad, Elias J Jabbour, Stephen W Gutkin, et al.
Current Medical Research and Opinion
|
February 6, 2014
Total and low-density lipoprotein cholesterol in high-risk patients treated with atorvastatin monotherapy in the United Kingdom: analysis of a primary-care database
Kevin Jameson, Qiaoyi Zhang, Changgeng Zhao, et al.
The Journal of Sexual Medicine
|
October 23, 2009
Sexual satisfaction in men with erectile dysfunction: correlates and potential predictors
Stanley E Althof, Jacques Buvat, Stephen W Gutkin, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Current Medical Research and Opinion
|
July 19, 2006
Effects of a global risk educational tool on primary coronary prevention: the Atherosclerosis Assessment Via Total Risk (AVIATOR) study
Terry A Jacobson, Stephen W Gutkin, Charles R Harper
European Journal of Endocrinology
|
March 7, 2008
Exploiting the antidiabetic properties of incretins to treat type 2 diabetes mellitus: glucagon-like peptide 1 receptor agonists or insulin for patients with inadequate glycemic control?
Luc F Van Gaal, Stephen W Gutkin, Michael A Nauck
Journal of Cardiovascular Pharmacology
|
April 23, 2008
Effects of modifying triglycerides and triglyceride-rich lipoproteins on cardiovascular outcomes
Madiha Abdel-Maksoud, Vasilisa Sazonov, Stephen W Gutkin, et al.
Clinicoeconomics and Outcomes Research : CEOR
|
June 21, 2018
A systematic literature review of the clinical and health economic burden of schizophrenia in privately insured patients in the United States
Wenjie Zhang, Tony B Amos, Stephen W Gutkin, et al.
Child and Adolescent Psychiatry and Mental Health
|
May 17, 2011
Time courses of improvement and symptom remission in children treated with atomoxetine for attention-deficit/hyperactivity disorder: analysis of Canadian open-label studies
Ruth A Dickson, Ellen Maki, Christopher Gibbins, et al.
Journal of the American Academy of Nurse Practitioners
|
June 9, 2011
Optimizing treatment outcomes with phosphodiesterase type 5 inhibitors for erectile dysfunction: opening windows to enhanced sexual function and overall health
Richard Sadovsky, Gerald B Brock, Mikel Gray, et al.
Current Medical Research and Opinion
|
December 7, 2007
Effects of ezetimibe, simvastatin, atorvastatin, and ezetimibe-statin therapies on non-cholesterol sterols in patients with primary hypercholesterolemia
Gerd Assmann, Frank Kannenberg, Dena R Ramey, et al.
Cancer Diagnosis & Prognosis
|
March 4, 2026
<i>BCR::ABL1</i> Mutational Profiling in US Patients With Chronic-phase Chronic Myeloid Leukemia on Tyrosine Kinase Inhibitors
Fadi G Haddad, Elias J Jabbour, Stephen W Gutkin, et al.
Current Medical Research and Opinion
|
February 6, 2014
Total and low-density lipoprotein cholesterol in high-risk patients treated with atorvastatin monotherapy in the United Kingdom: analysis of a primary-care database
Kevin Jameson, Qiaoyi Zhang, Changgeng Zhao, et al.
The Journal of Sexual Medicine
|
October 23, 2009
Sexual satisfaction in men with erectile dysfunction: correlates and potential predictors
Stanley E Althof, Jacques Buvat, Stephen W Gutkin, et al.
Page
of 2